User profiles for Gil Yosipovitch
Gil YosipovitchProfessor of Dermatology, Miami University Verified email at med.miami.edu Cited by 29643 |
Obesity and the skin: skin physiology and skin manifestations of obesity
G Yosipovitch, A DeVore, A Dawn - Journal of the American Academy of …, 2007 - Elsevier
Obesity is widely recognized as an epidemic in the Western world; however, the impact of
obesity on the skin has received minimal attention. The purpose of this article is to highlight the …
obesity on the skin has received minimal attention. The purpose of this article is to highlight the …
Skin pH: from basic science to basic skin care
SM Ali, G Yosipovitch - Acta dermato-venereologica, 2013 - medicaljournalssweden.se
The “acid mantle” is a topic not only of historical interest, but also of clinical significance and
has recently been linked to vital stratum corneum function. Despite compelling basic science …
has recently been linked to vital stratum corneum function. Despite compelling basic science …
The neurobiology of itch
…, M Steinhoff, S Ständer, G Yosipovitch… - Nature reviews …, 2006 - nature.com
The neurobiology of itch, which is formally known as pruritus, and its interaction with pain
have been illustrated by the complexity of specific mediators, itch-related neuronal pathways …
have been illustrated by the complexity of specific mediators, itch-related neuronal pathways …
Chronic pruritus
G Yosipovitch, JD Bernhard - New England Journal of Medicine, 2013 - Mass Medical Soc
Key Clinical Points Chronic Pruritus Chronic pruritus (itching that persists for more than 6
weeks) may be caused by inflammatory skin diseases, systemic diseases, neuropathic …
weeks) may be caused by inflammatory skin diseases, systemic diseases, neuropathic …
[PDF][PDF] Clinical classification of itch: a position paper of the International Forum for the Study of Itch
…, MW Greaves, M Schmelz, G Yosipovitch… - ACTA …, 2007 - academia.edu
Acta Derm Venereol 87 tent definitions of clinical terms and classifications of pruritus befitting
the enormity and complexity of this clinical problem. This is the first version of a clinical …
the enormity and complexity of this clinical problem. This is the first version of a clinical …
Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised …
…, M Cork, T Bieber, JP Thyssen, G Yosipovitch… - The Lancet, 2020 - thelancet.com
Background Abrocitinib, an oral selective Janus kinase 1 inhibitor, was effective and well
tolerated in adults with moderate-to-severe atopic dermatitis in a phase 2b trial. We aimed to …
tolerated in adults with moderate-to-severe atopic dermatitis in a phase 2b trial. We aimed to …
Itch
G Yosipovitch, MW Greaves, M Schmelz - The Lancet, 2003 - thelancet.com
Itch is a common skin sensation, with substantial effects on behaviour. Neurophysiological
research has permitted accurate definition of neural pathways of itch, and has confirmed the …
research has permitted accurate definition of neural pathways of itch, and has confirmed the …
Itch: from mechanism to (novel) therapeutic approaches
G Yosipovitch, JD Rosen, T Hashimoto - Journal of allergy and clinical …, 2018 - Elsevier
Itch is a common sensory experience that is prevalent in patients with inflammatory skin
diseases, as well as in those with systemic and neuropathic conditions. In patients with these …
diseases, as well as in those with systemic and neuropathic conditions. In patients with these …
[HTML][HTML] Time-dependent variations of the skin barrier function in humans: transepidermal water loss, stratum corneum hydration, skin surface pH, and skin …
G Yosipovitch, GL Xiong, E Haus… - Journal of investigative …, 1998 - Elsevier
Although circadian rhythms have been described formany human functions, there are minimal
data on circadian rhythms related to skin physiology. This study investigated the circadian …
data on circadian rhythms related to skin physiology. This study investigated the circadian …
[HTML][HTML] Phase 3 trial of nemolizumab in patients with prurigo nodularis
SG Kwatra, G Yosipovitch, FJ Legat… - … England Journal of …, 2023 - Mass Medical Soc
Background Prurigo nodularis is a chronic, debilitating, and severely pruritic neuroimmunologic
skin disease. Nemolizumab, an interleukin-31 receptor alpha antagonist, down-…
skin disease. Nemolizumab, an interleukin-31 receptor alpha antagonist, down-…